Comparison of Normal Saline Versus Ringer's Lactated Solution for Fluid Resuscitation in Patients with Acute Pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20161010001

Enrollment

Registered

2016-10-10

Start date

2016-10-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age more than eighteen years with acute pancreatitis

Interventions

Patient with acute pancreatitis will receive Normal saline solution in A arm of treatment after computerized four by four randomization,Patient with acute pancreatitis will receive Ringer&#39

s lactated solution in B arm of treatment after computerized four by four randomization

Experimental Drug,Experimental Drug

Normal saline group,RLS group

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient with acute pancreatitis

Exclusion criteria

Exclusion criteria: Have any problem than can not be safe with fluid therapy

Design outcomes

Primary

Measure	Time frame
Mortality in acute pancreatitis 30 day Percent	—

Secondary

Measure	Time frame
SIRs and organ failure in acute pancreatitis 24 and 48 hours and 30 days Percent	—

Countries

Thailannd

Contacts

Public ContactSararak Choosakul

Fellow

Sararakk@hotmail.com0819116536

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Comparison of Normal Saline Versus Ringer&#39;s Lactated Solution for Fluid Resuscitation in Patients with Acute Pancreatitis